High-Dose steroid trial aims to ease agony after lung cancer surgery
NCT ID NCT07213375
Summary
This study is testing if a higher dose of a common steroid (dexamethasone) can better control pain after minimally invasive lung cancer surgery. It focuses on patients who are identified as being highly sensitive to pain before their operation. Researchers will compare a high dose to a standard low dose to see which one helps patients feel less pain when they cough the morning after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department for Cardiothoracic Surgery, Rigshospitalet
RECRUITINGCopenhagen, Copenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.